SCHEMBL23482736

SCHEMBL23482736

CC(C)NC(=O)C(C)C(C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ GAA P10253 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ MMP8 P22894 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ ACE P12821 2/20 0.34
▸ MME P08473 1/20 0.32
▸ CPA1 P15085 1/20 0.32
▸ ACE2 Q9BYF1 1/20 0.32
▸ FOLH1 Q04609 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909884 0.78 CA12 (0.40) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL12724859 0.78 CA12 (0.40) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL18909885 0.78 CA12 (0.40) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL812166 0.76 TP53 (0.57) ALDH1A1LMNATSHRTP53THRB
SCHEMBL13310465 0.76 TP53 (0.57) ALDH1A1LMNATSHRTP53THRB
SCHEMBL812149 0.76 TP53 (0.57) ALDH1A1LMNATSHRTP53THRB
SCHEMBL715386 0.76 TP53 (0.57) ALDH1A1LMNATSHRTP53THRB
SCHEMBL83830 0.76 TP53 (0.57) ALDH1A1LMNATSHRTP53THRB
SCHEMBL14034686 0.76 TP53 (0.38) ALDH1A1GAAMEN1KMT2ALMNA
SCHEMBL9911497 0.76 ALDH1A1 (0.41) ALDH1A1GAAMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210169896-A1 A CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210169896-A1 A CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES PBDC1, BRD2, CD79B ALDH1A1 2260/4885GAA 3636/4885MEN1 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback